This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated September quarter revenue up 22.5%, profit after tax up 17.3%
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
In the consolidated quarter ended 30 September 2026 versus the year-earlier quarter, revenue rose 22.5% from Rs 537.47 crore to Rs 658.59 crore, while profit after tax rose 17.3% from Rs 83.84 crore to Rs 98.32 crore. The margin before interest, tax, depreciation and amortisation widened from 27.1% to 28.3%. For the consolidated six months ended 30 September 2026, revenue was Rs 1,212.87 crore and profit after tax was Rs 171.60 crore.
Strong revenue and margin gains support earnings, though profit growth below revenue growth may temper the positive stock reaction.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹658.6 Cr | ₹537.5 Cr | +22.5% |
| Operating profit | ₹127.3 Cr | ₹96.73 Cr | +31.6% |
| Profit after tax | ₹98.32 Cr | ₹83.84 Cr | +17.3% |
| EBITDA margin | 28.3% | 27.1% | +1.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.